Executive Summary

Daily International Pharma Alert is a free email newsletter published by FDAnews. It’s one of seven free emails they offer and promises to deliver:

“Daily pharmaceutical news affecting companies around the world”

In writing this review I analyzed five recent issues, published February 7th, 8th, 9th, 12th and 13th (they only publish on weekdays).

I found a lot to like about the newsletter:

• The from line is used very effectively.
• It does a good job of supporting the business goals.
• FDAnews includes a word-of-mouth call to action to help grow their list.

And a few things that could be improved upon:

• A table of contents would help readers quickly identify articles of interest.
• An opening paragraph would give the newsletter a more personable feel.
• Shifting the ad spaces so they don’t overload the preview pane would make it more engaging.

Bottom line: Daily International Pharma Alert is a study in extremes. On our scorecard it earned four A’s but also an F and a D. A little more attention to some small details will help improve the reader experience and should lift response.